For research use only. Not for use in humans.

Lecanemab (Anti-Amyloid Beta)

Synonyms: BAN-2401 Cat.No.A3112 Purity:99%

Lecanemab (Anti-Amyloid Beta) is a humanised IgG1 monoclonal antibody targeting soluble aggregated amyloid beta (Aβ). It can be used for the research of Alzheimer's Disease. MW :147.06 KD.

1 Citation

17 Nobel Prize winners
have used Selleck products

Shimon Sakaguchi

Nature Communications 2025;16, Article number:1325

David Baker

Dev Cell 2023;58(20):2163-2180.e9.

Michael Houghton

Cell Chem Biol 2020;27(7):780-792.e5

David Julius

Cell 2017;185-198.e16

Charles M. Rice

Cell 2018;172(3):423-438.e25

Quality Control

Batch: Purity: 99% Protein concentration: 5.451mg/ml Endotoxin Level: ＜1EU/mg

Specificity

Name	Citation	Beta Amyloid	Others
DAPT	398	++
RO4929097 (RG-4733)	124	+++	γ secretase,γ secretase(ICN)
MK-0752	23	+++
Avagacestat (BMS-708163)	22	++++
LY2811376	19	+	BACE1
Tabersonine hydrochloride	0	✔
EUK 134	6	✔

Expand to Check More

1. "+" indicates inhibitory effect. Increased inhibition is marked by a higher "+" designation.
2. "✔" indicates inhibitory effect, but without specific value.

Mechanism of Action

Description	Lecanemab (Anti-Amyloid Beta) is a humanised IgG1 monoclonal antibody targeting soluble aggregated amyloid beta (Aβ). It can be used for the research of Alzheimer's Disease. MW :147.06 KD.
References	[1] https://pubmed.ncbi.nlm.nih.gov/36544184/

Cell Lines	Assay Type	Concentration	Incubation Time	Formulation	Activity Description	PMID

Product Details

CAS No.	1260393-98-3
Isotype	Human IgG1
Source	CHO
Formulation	100 mM Pro-Ac, 20mM Arg, pH5.0
Storage	Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

^*Literature analysis of various clone (for this target) products available on the market shows that Sellecks selected clones are more frequently applied. (data until September 2024)

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.